Neurology News

Healio has reached an exciting milestone, as the website celebrates its 10-year anniversary. Since its launch in April 2012, Healio has been committed to delivering physicians and medical professionals the information they need to stay informed and improve patient health.

SEATTLE — Higher frequency of seizures and relatively poor quality of life are significant risk factors for depression in patients with epilepsy, according to a presentation at the 2022 American Academy of Neurology annual meeting.

The first quarter of 2022 has served as a stark reminder that financial markets can decline — and decline quickly.

The presence of newborn neurons and an immature version of a related cell, known as astroglia, were found in patients with epilepsy, researchers reported in Nature Neuroscience.

SEATTLE — A decrease in the severity of tics in children and adolescents with Tourette syndrome was observed following the use of ecopipam, according to data presented at the 2022 American Academy of Neurology annual meeting.

CMS announced that Medicare is limiting coverage of the controversial Alzheimer’s disease drug Aduhelm to participants who are enrolled in FDA- or NIH-approved clinical trials.

SEATTLE — Abnormalities during sleep may be associated with neurological conditions, Alberto Ramos, MD, a sleep disorder specialist at the University of Miami, said at the 2022 American Academy of Neurology annual meeting.

Researchers identified significant U-shaped associations between sleep duration and cardiovascular mortality, 10-year atherosclerotic CVD risk and C-reactive protein, a marker of inflammation.

SEATTLE — Fatigue is a frequent concern for patients with MS in the United Kingdom and has multiple predictors, according to a presenter at the 2022 American Academy of Neurology annual meeting.

In this week's edition, the FDA approval of a transdermal patch to treat Alzheimer’s-related dementia; the link between daily napping and an increased risk for Alzheimer’s disease; an oral treatment for Parkinson’s; and more.